Home › Multiple Myeloma › California › Sacramento
Pag-aaral pangklinika para sa Multiple Myeloma sa Sacramento, CA
Isang pag-aaral para sa Multiple Myeloma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Sacramento. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Nagre-recruitPhase 3
- Research Site, Sacramento
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Nagre-recruitPhase 2
- Kaiser Permanente - Sacramento Medical Center, Sacramento
- Sutter Sacramento, Sacramento
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
Nagre-recruitObservasyonal na pag-aaral
- University of California Davis Comprehensive Cancer Center, Sacramento
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Nagre-recruitPhase 3
- University of California Davis (UC Davis) Comprehensive Cancer Center, Sacramento
- University of California, Sacramento
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Nagre-recruitPhase 3
- Mercy Cancer Center - Sacramento, Sacramento
- Woodland Memorial Hospital, Woodland · 16 mi ang layo
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
Nagre-recruitPhase 1
- UC Davis Comprehensive Cancer Center, Sacramento
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Nagre-recruitPhase 3
- Mercy Cancer Center - Sacramento, Sacramento
- University of California Davis Comprehensive Cancer Center, Sacramento
- Woodland Memorial Hospital, Woodland · 16 mi ang layo
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Nagre-recruitPhase 3
- University of California-Davis Cancer Center, Sacramento
Pag-aaral para sa Multiple Myeloma sa ibang lungsod
- New York City, NY60 pag-aaral
- Boston, MA42 pag-aaral
- Atlanta, GA42 pag-aaral
- Houston, TX38 pag-aaral
- Durham, NC37 pag-aaral
- Nashville, TN32 pag-aaral
- Denver, CO27 pag-aaral
- St. Louis, MO24 pag-aaral
- Rochester, MN24 pag-aaral
- Columbus, OH24 pag-aaral
- Baldwin Park, CA23 pag-aaral
- Edison, NJ22 pag-aaral
Iba pang pag-aaral sa Sacramento
- Non-Small Cell Lung Cancer29 pag-aaral
- Kanser sa Baga22 pag-aaral
- Kanser sa Suso20 pag-aaral
- Kanser sa Prostate19 pag-aaral
- Metastatic Cancer16 pag-aaral
- Acute Myeloid Leukemia12 pag-aaral
- Pagkabigo ng Puso12 pag-aaral
- Kanser sa Pancreas12 pag-aaral
- Kanser (lahat ng uri)11 pag-aaral
- Colon Cancer11 pag-aaral
- Kanser sa Pantog10 pag-aaral
- Colorectal Cancer10 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.